Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 15529553 | HLA-DR (HLA-DR) | ectasia | NA | NA | NA | unclassified | |
| hla-dr b1 and dq b1 polymorphisms in patients with coronary artery ectasia. | |||||||
| 15529553 | HLA-CLASS II (HLA CLASS II) | ectasia | NA | NA | NA | unclassified | |
| sthe purpose of our study was to evaluate the significance of polymorphisms in hla class ii genes in coronary artery ectasia (cae) patients. | |||||||
| 15535133 | HLA-DR (HLA-DR) | prion diseases | NA | NA | NA | unclassified | |
| in order to test this hypothesis in prion diseases, samples from cerebral cortex, striatum, thalamus, and cerebellum from 14 patients with creutzfeldt-jakob disease (8 sporadic, 2 familial, 2 iatrogenic, and 2 variant), and 4 with fatal familial insomnia (3 homozygous met/met at codon 129 of the prnp gene, 1 heterozygous met/val), and 3 controls were immunostained for eaat-1, gfap, hla-dr, cd68, il-1, caspase 3, and prp. | |||||||
| 15535133 | HLA-DR (HLA-DR) | fatal familial insomnia | NA | NA | NA | unclassified | |
| in order to test this hypothesis in prion diseases, samples from cerebral cortex, striatum, thalamus, and cerebellum from 14 patients with creutzfeldt-jakob disease (8 sporadic, 2 familial, 2 iatrogenic, and 2 variant), and 4 with fatal familial insomnia (3 homozygous met/met at codon 129 of the prnp gene, 1 heterozygous met/val), and 3 controls were immunostained for eaat-1, gfap, hla-dr, cd68, il-1, caspase 3, and prp. | |||||||
| 15546587 | HLA (HLA) | focal myositis | NA | NA | NA | unclassified | |
| hla typing in focal myositis. | |||||||
| 15546587 | HLA (HLA) | focal myositis | NA | NA | NA | unclassified | |
| we present here four patients, including identical twins, with focal myositis accompanied by the same hla typings. | |||||||
| 15553443 | HLA (HLA) | hemorrhoid | NA | NA | NA | unclassified | |
| circumferential mucosectomy with a stapler, diathermic hemorrhoidectomy with high frequency devices, and the hla doppler ii system have significantly modified the classical indications for the treatment of the disease. | |||||||
| 15555354 | HLA-B*27 | spinal diseases | Chinese | NA | NA | unclassified | |
| 4-phase survey was conducted in 21 750 chinese army, including: face-to-face interviews with standardized copcord questionnaires (phase i screening); further examination on the suspected cases; identification of inflammatory joint and spinal diseases (phase ii); identification of spas (as and uspa) by more than two experienced specialists in rheumatology; further examination with x-rays and laboratory detection of hla-b27 (phase iii); and data analysis (phase iv). | |||||||
| 16415899 | HLA IDENTICAL (HLA-IDENTICAL) | hematological disease | NA | NA | NA | unclassified | |
| to assess the significance of homozygous gstm1 and gstt1 gene deletion in hsct, we analyzed dna from 373 patients with hematological disease and their hla-identical unrelated bone marrow donors using pcr. | |||||||
| 15621895 | HLA (HLA) | disorders chromosomal | NA | NA | NA | unclassified | |
| since its introduction in 1990 this approach has been applied to an increasing number of single gene disorders, chromosomal rearrangements, and more recent indications such as aneuploidy screening and hla matching. | |||||||
Copyright 2024